Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_assertion description "[We studied the incidences, associations, and prognostic roles of NOTCH1 and SF3B1 mutations (NOTCH1(mut), SF3B1(mut)) as compared with TP53(mut) in fludarabine-refractory chronic lymphocytic leukemia (CLL) patients treated with alemtuzumab in the CLL2H trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_assertion evidence source_evidence_literature NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_assertion SIO_000772 23821658 NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_assertion wasDerivedFrom befree-2016 NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_assertion wasGeneratedBy ECO_0000203 NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.
- befree-2016 importedOn "2016-02-19" NP1090945.RAw0iZYrrLytMPvEuQa1vX1cnrO3zjHF6qNU7Yg-f-33E130_provenance.